Naomoto Y - Search Results

1

Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.

Hao HF, Takaoka M, Bao XH, Wang ZG, Tomono Y, Sakurama K, Ohara T, Fukazawa T, Yamatsuji T, Fujiwara T, Naomoto Y. Hao HF, et al. Among authors: naomoto y. Biochem Biophys Res Commun. 2012 Jul 13;423(4):744-9. doi: 10.1016/j.bbrc.2012.06.030. Epub 2012 Jun 13. Biochem Biophys Res Commun. 2012. PMID: 22705303 Free article.

2

The impact of triple drug immunosuppression on clinical results of cadaveric kidney transplantation: a comparison of conventional immunosuppression.

Sakagami K, Saito S, Shiozaki S, Takasu S, Matsuno T, Fujiwara T, Kusaka S, Uda M, Matsuoka J, Naomoto Y, et al. Sakagami K, et al. Among authors: naomoto y. Acta Med Okayama. 1992 Feb;46(1):53-6. doi: 10.18926/AMO/32683. Acta Med Okayama. 1992. PMID: 1561907 Free article.

3

Cyclin A and Cdk2 kinase activity are suppressed by combined treatment with tumor necrosis factor-alpha and interferon-alpha.

Satomoto K, Haisa M, Naomoto Y, Tanaka N, Orita K. Satomoto K, et al. Among authors: naomoto y. Biochem Biophys Res Commun. 1995 Aug 24;213(3):1115-21. doi: 10.1006/bbrc.1995.2242. Biochem Biophys Res Commun. 1995. PMID: 7654228

4

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers.

Hamada M, Fujiwara T, Hizuta A, Gochi A, Naomoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N, Orita K. Hamada M, et al. Among authors: naomoto y. J Cancer Res Clin Oncol. 1996;122(6):360-5. doi: 10.1007/BF01220804. J Cancer Res Clin Oncol. 1996. PMID: 8642047

5

Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein.

Hamada M, Naomoto Y, Fujiwara T, Kamikawa Y, Tanaka N. Hamada M, et al. Among authors: naomoto y. Jpn J Clin Oncol. 1996 Dec;26(6):398-404. doi: 10.1093/oxfordjournals.jjco.a023255. Jpn J Clin Oncol. 1996. PMID: 9001343

6

In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer.

Perdomo JA, Naomoto Y, Haisa M, Fujiwara T, Hamada M, Yasuoka Y, Tanaka N. Perdomo JA, et al. Among authors: naomoto y. J Cancer Res Clin Oncol. 1998 Jan;124(1):10-8. doi: 10.1007/s004320050127. J Cancer Res Clin Oncol. 1998. PMID: 9498829

7

Tuberculosis of the esophagus.

Perdomo JA, Naomoto Y, Haisa M, Yamatsuji T, Kamikawa Y, Tanaka N. Perdomo JA, et al. Among authors: naomoto y. Dis Esophagus. 1998 Jan;11(1):72-4. Dis Esophagus. 1998. PMID: 9595240

8

Primary malignant melanoma of the esophagus: report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy.

Naomoto Y, Perdomo JA, Kamikawa Y, Haisa M, Yamatsuji T, Kenzo A, Taguchi K, Hara K, Tanaka N. Naomoto Y, et al. Jpn J Clin Oncol. 1998 Dec;28(12):758-61. doi: 10.1093/jjco/28.12.758. Jpn J Clin Oncol. 1998. PMID: 9879295

9

Multiple primary cancers of the esophagus and thyroid gland.

Naomoto Y, Haisa M, Yamatsuji T, Shirakawa Y, Muramatsu T, Isozaki H, Kamikawa Y, Tanaka N. Naomoto Y, et al. Jpn J Clin Oncol. 1999 Jul;29(7):349-52. doi: 10.1093/jjco/29.7.349. Jpn J Clin Oncol. 1999. PMID: 10470660 Review.

10

Multiple liver metastases of breast cancer: report of a case successfully treated with hormone-cytokine-chemotherapy.

Naomoto Y, Sadamori H, Matsukawa H, Shirakawa Y, Yamatsuji T, Saito S, Hino N, Isozaki H, Takakura N, Tanaka N. Naomoto Y, et al. Jpn J Clin Oncol. 1999 Aug;29(8):390-4. doi: 10.1093/jjco/29.8.390. Jpn J Clin Oncol. 1999. PMID: 10494924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters